Filip Cools

Filip Cools is a Physician Scientist affiliated with the Vrije Universiteit Brussel (VUB), working in the Neonatology department at the University Hospital Brussels (UZB). With over 24 Scopus-cited publications and an h-index of 24, his research focuses on preterm infant care, systematic reviews, and clinical practice guidelines.

Key research areas include preterm infant mortality, perinatal palliative care, respiratory support protocols, and parenteral nutrition adherence. His work spans clinical trials (e.g., BENEFICIAL trial on vancomycin dosing, 2024), systematic reviews (e.g., NAVA in NICU, 2024), and feasibility studies (e.g., standardized parenteral nutrition, 2021).

Recent publications highlight trends in neonatal anemia management (2025), end-of-life decision-making (2024), and pharmacokinetics of morphine in encephalopathic neonates (2019). His collaborative projects involve institutions like Ghent University and European NICU networks.

Scientific leadership includes chairing conferences (e.g., Use of NAVA in NICU, 2024) and supervising theses on topics like CLABSI prevention (2018) and maternal bariatric surgery effects (2020). His datasets on perinatal palliative care (2025) and neonatal respiratory distress (2019) are openly available.